30 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Full Sequence Amino Acid Scanning of¿-Defensin RTD-1 Yields a Potent Anthrax Lethal Factor Protease Inhibitor.
State University Of New York
Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
University Of Minnesota
Exploring the influence of the protein environment on metal-binding pharmacophores.
University Of California
Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.
Panthera Biopharma
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
Microbiotix
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
University Of California
Antidotes to anthrax lethal factor intoxication. Part 2: structural modifications leading to improved in vivo efficacy.
Panthera Biopharma
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
University Of California
Antidotes to anthrax lethal factor intoxication. Part 1: Discovery of potent lethal factor inhibitors with in vivo efficacy.
Panthera Biopharma
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin.
National Institute Of Allergy And Infectious Diseases
Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors.
Institute For Medical Research
Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.
Institute For Medical Research
In-cell production of a genetically-encoded library based on the ?-defensin RTD-1 using a bacterial expression system.
University Of Southern California
In silico binding analysis and SAR elucidations of newly designed benzopyrazine analogs as potent inhibitors of thymidine phosphorylase.
Universiti Teknologi Mara (Uitm)
D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs.
Case Western Reserve University
Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism.
University Of North Carolina At Chapel Hill
Discovery of a New Class of Potent, Selective, and Orally Bioavailable CRTH2 (DP2) Receptor Antagonists for the Treatment of Allergic Inflammatory Diseases.
Merck Serono
Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors.
Lund University